Skip to main content

Table 2 Harzard ratios for time to death by type of cancer using univariate Cox regressiona

From: Health litigation and cancer survival in patients treated in the public health system in a large Brazilian city, 2014–2019

Variable

Levels

Type of cancer

Breast

Prostate

Colon

Lung

Brain

HR

L95

U95

p

HR

L95

U95

p

HR

L95

U95

p

HR

L95

U95

p

HR

L95

U95

p

Age

-

1.01

1.00

1.01

0.07

1.03

1.02

1.04

0.00

1.00

1.00

1.01

0.24

1.01

1.00

1.02

0.00

1.03

1.02

1.04

0.00

Sex

Female

-

-

-

-

-

-

-

-

1.00

-

-

0.00

1.00

-

-

0.00

1.00

-

-

 

Male

-

-

-

-

-

-

-

-

1.29

1.09

1.54

 

1.26

1.09

1.46

 

0.89

0.65

1.22

0.48

Race/Color

Non-white

1.00

  

0.11

1.00

  

0.89

1.00

  

0.24

1.00

  

0.25

1.00

  

0.41

White

0.81

0.66

0.99

 

0.95

0.70

1.28

 

0.85

0.68

1.06

 

1.06

0.88

1.27

 

1.07

0.73

1.57

 

Missing

0.92

0.61

1.38

 

0.92

0.59

1.44

 

1.14

0.77

1.70

 

0.77

0.54

1.11

 

1.69

0.82

3.46

 

Surgery for cancer

No

1.00

  

0.00

1.00

  

0.00

1.00

  

0.00

1.00

  

0.00

1.00

  

0.27

Yes

0.46

0.38

0.54

 

0.16

0.11

0.23

 

0.70

0.58

0.83

 

0.46

0.38

0.57

 

0.82

0.59

1.16

 

Nonhormonal chemotherapy

No

1.00

  

0.00

1.00

  

0.00

1.00

  

0.37

1.00

  

0.00

1.00

  

0.00

Palliative

4.11

3.12

5.40

 

2.15

1.41

3.27

 

1.08

0.41

2.87

 

0.43

0.32

0.57

 

0.53

0.35

0.78

 

Nonpalliative

5.69

4.58

7.06

  

0.77

0.28

2.12

 

0.30

0.20

0.45

  

Hormonal chemotherapy

No

1.00

  

0.00

1.00

  

0.00

-

-

-

-

-

-

-

-

-

-

-

-

Palliative

0.35

0.27

0.44

 

0.43

0.30

0.60

-

-

-

-

-

-

-

-

-

-

-

-

-

Nonpalliative

0.11

0.09

0.14

 

0.30

0.13

0.71

 

-

-

-

-

-

-

-

-

-

-

-

-

Orchiectomy or ovariectomy

No

1.00

  

0.70

1.00

  

0.00

-

-

-

-

-

-

-

-

-

-

-

-

Yes

1.20

0.50

2.89

 

1.83

1.47

2.28

 

-

-

-

-

-

-

-

-

-

-

-

-

Radiation therapy

No

1.00

  

0.00

1.00

  

0.00

1.00

  

0.71

1.00

  

0.14

1.00

  

0.00

Palliative

1.31

1.03

1.67

 

1.03

0.77

1.39

-

1.12

0.79

1.58

 

0.88

0.73

1.06

 

0.16

0.06

0.45

 

Nonpalliative

0.43

0.35

0.53

 

0.28

0.18

0.43

 

0.70

0.17

2.81

 

0.78

0.59

1.04

 

0.61

0.44

0.84

 

Elective hospitalization

No

1.00

  

0.00

1.00

  

0.00

1.00

  

0.00

1.00

  

0.00

1.00

  

0.00

Yes

0.38

0.28

0.51

 

0.45

0.32

0.63

 

0.44

0.32

0.62

 

0.31

0.19

0.50

 

0.31

0.15

0.63

 

Urgent hospitalization

No

1.00

  

0.00

1.00

  

0.00

1.00

  

0.02

1.00

  

0.00

1.00

  

0.00

Yes

4.30

3.02

6.12

 

3.05

2.08

4.45

 

1.48

1.06

2.08

 

1.76

1.28

2.43

 

2.48

1.22

5.05

 

Time (in days) from diagnosis to start of treatment

Up to 60 days

1.00

  

0.27

1.00

  

0.00

1.00

  

0.33

1.00

  

0.21

1.00

  

0.67

More than 60 days

0.91

0.78

1.07

 

2.40

1.78

3.23

 

0.91

0.76

1.10

 

1.10

0.95

1.27

 

1.08

0.76

1.52

 

Type of lung cancer

Non-small cells

-

-

-

-

-

-

-

 

-

-

-

-

1.00

  

0.00

-

-

-

-

Small cells

-

-

-

-

-

-

-

-

-

-

-

-

1.57

1.21

2.05

 

-

-

-

-

Not specified

-

-

-

-

-

-

-

-

-

-

-

-

1.63

1.35

1.97

-

-

-

-

-

Filed legal action against the state

No

1.00

  

0.94

1.00

  

0.23

1.00

  

0.06

1.00

  

0.00

1.00

  

0.22

Yes

1.02

0.66

1.58

 

0.74

0.44

1.24

 

0.66

0.42

1.04

 

0.40

0.25

0.65

 

0.75

0.47

1.20

 
  1. Abbreviations: HR Hazard ratio, L95 Lower 95% CI bound for the Hazard Ratio, U95 Upper 95% CI bound for the Hazard Ratio, p p-value
  2. aUnivariate analysis with staging as a control variable (except for brain cancer)